These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37278501)

  • 1. Pso-Reg: a web registry for psoriasis in real life.
    Trovato E; Cartocci A; Calabrese L; D'Onghia M; Dragotto M; Capalbo E; Silvi G; Manzo Margiotta F; Pimpinelli N; Pellegrino M; Romanelli M; Dini V; Cuccia A; Mazzatenta C; Rubegni P; Prignano F
    Ital J Dermatol Venerol; 2023 Jun; 158(3):249-254. PubMed ID: 37278501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale and Design of the Brigham Cohort for psoriasis and psoriatic arthritis registry (COPPAR).
    Schneeweiss M; Merola JF; Karlson EW; Solomon DH
    BMC Dermatol; 2017 Aug; 17(1):11. PubMed ID: 28814312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaco-utilization of biologic drugs in patients affected by psoriasis, psoriatic arthritis and ankylosing spondylitis in an Italian real-world setting.
    Zagni E; Colombo D; Fiocchi M; Perrone V; Sangiorgi D; Andretta M; De Sarro G; Nava E; Degli Esposti L
    Expert Rev Pharmacoecon Outcomes Res; 2020 Oct; 20(5):491-497. PubMed ID: 32701033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coprevalence of Hidradenitis Suppurativa and Psoriasis: Detailed Demographic, Disease Severity and Comorbidity Pattern.
    Pinter A; Sarlak M; Zeiner KN; Malisiewicz B; Kaufmann R; Romanelli M; Koenig A; Chiricozzi A
    Dermatology; 2021; 237(5):759-768. PubMed ID: 33326954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy and safety of certolizumab pegol in cutaneous symptoms on psoriasis in patients with psoriatic arthritis: A retrospective analysis in real life.
    Dattola A; Mazzeo M; Di Stefano F; Manfreda V; Vollono L; Di Raimondo C; Di Matteo E; Bianchi L
    Dermatol Ther; 2020 May; 33(3):e13409. PubMed ID: 32291887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study.
    Chiricozzi A; Zangrilli A; Bavetta M; Bianchi L; Chimenti S; Saraceno R
    J Eur Acad Dermatol Venereol; 2017 Feb; 31(2):304-311. PubMed ID: 27324646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey.
    Potenza MC; Peris K; Berardesca E; Bianchi L; Richetta A; Bernardini N; De Simone C; Teoli M; Zangrilli A; D'epiro S; Orsini D; Narcisi A; Chimenti S; Costanzo A
    Dermatol Ther; 2018 Jan; 31(1):. PubMed ID: 29215183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and Treatment of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis in Germany: A Real-World Evidence Study.
    Grellmann C; Dombrowsky W; Fabricius V; Suruki R; Sheahan A; Joeres L
    Adv Ther; 2021 Jan; 38(1):366-385. PubMed ID: 33128201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating the skin with biologics in patients with psoriasis decreases the incidence of psoriatic arthritis.
    Acosta Felquer ML; LoGiudice L; Galimberti ML; Rosa J; Mazzuoccolo L; Soriano ER
    Ann Rheum Dis; 2022 Jan; 81(1):74-79. PubMed ID: 34281904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL36G genetic variant is independently associated with susceptibility, severity and joint involvement in psoriasis.
    Moreira CR; de Alcântara CC; Flauzino T; Martin LMM; Lozovoy MAB; Reiche EMV; Simão ANC
    Mol Immunol; 2023 Jul; 159():69-75. PubMed ID: 37285630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of patients with psoriasis potentially eligible and currently untreated with biological drugs in Italy.
    Degli Esposti L; Perrone V; Dovizio M; Sangiorgi D; DI Cesare A; Rosi E; Peris K; Prignano F
    Ital J Dermatol Venerol; 2023 Dec; 158(6):445-451. PubMed ID: 37768706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of the validated Psoriasis Epidemiology Screening Tool to identify signs and symptoms of psoriatic arthritis among those with psoriasis: a cross-sectional analysis from the US-based Corrona Psoriasis Registry.
    Mease PJ; Palmer JB; Hur P; Strober BE; Lebwohl M; Karki C; Reed GW; Etzel CJ; Greenberg JD; Helliwell PS
    J Eur Acad Dermatol Venereol; 2019 May; 33(5):886-892. PubMed ID: 30663130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and risk profile of psoriasis patients included in the Czech national registry BIOREP and a comparison with other registries.
    Kojanova M; Fialova J; Cetkovska P; Gkalpakiotis S; Jircikova J; Dolezal T; Arenberger P;
    Int J Dermatol; 2017 Apr; 56(4):428-434. PubMed ID: 28181669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104-week multicenter retrospective study - IL PSO (ITALIAN LANDSCAPE PSORIASIS).
    Gargiulo L; Ibba L; Malagoli P; Angileri RG; Bardazzi F; Bernardini N; Burlando M; Carrera CG; Chiricozzi A; Dapavo P; Dini V; Fabbrocini G; Gaiani FM; Galluzzo M; Giofré C; Guarneri C; Loconsole F; Malara G; Marcelli L; Megna M; Piaserico S; Talamonti M; Costanzo A; Narcisi A
    J Eur Acad Dermatol Venereol; 2023 May; 37(5):1017-1027. PubMed ID: 36695061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Unmet Needs and Treatment Patterns of Paediatric Psoriasis Patients: A Real-World Evidence Study in Spain.
    de Lucas R; Vicente A; Richardson C; Lucas J; Gillespie-Akar L; Gómez-Labrador L; Torrelo A
    Actas Dermosifiliogr; 2023 May; 114(5):T382-T391. PubMed ID: 37088286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Unmet Needs and Treatment Patterns of Paediatric Psoriasis Patients: A Real-World Evidence Study in Spain.
    de Lucas R; Vicente A; Richardson C; Lucas J; Gillespie-Akar L; Gómez Labrador L; Torrelo A
    Actas Dermosifiliogr; 2023 May; 114(5):382-391. PubMed ID: 36907550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of Patient Perceptions of Psoriatic Disease: Results from the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Survey.
    Lebwohl M; Langley RG; Paul C; Puíg L; Reich K; van de Kerkhof P; Wu HL; Richter S; Jardon S; Gisondi P
    Dermatol Ther (Heidelb); 2022 Jan; 12(1):61-78. PubMed ID: 34704231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
    Mazzotta A; Esposito M; Costanzo A; Chimenti S
    Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited association between scalp psoriasis and psoriatic arthritis severity and treatment response.
    de Vlam K; Mallbris L; Szumski A; Jones H
    Clin Exp Rheumatol; 2017; 35(1):141-144. PubMed ID: 27606545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries.
    Machado PM; Schäfer M; Mahil SK; Liew J; Gossec L; Dand N; Pfeil A; Strangfeld A; Regierer AC; Fautrel B; Alonso CG; Saad CGS; Griffiths CEM; Lomater C; Miceli-Richard C; Wendling D; Alpizar Rodriguez D; Wiek D; Mateus EF; Sirotich E; Soriano ER; Ribeiro FM; Omura F; Rajão Martins F; Santos H; Dau J; Barker JN; Hausmann J; Hyrich KL; Gensler L; Silva L; Jacobsohn L; Carmona L; Pinheiro MM; Zelaya MD; Severina MLÁ; Yates M; Dubreuil M; Gore-Massy M; Romeo N; Haroon N; Sufka P; Grainger R; Hasseli R; Lawson-Tovey S; Bhana S; Pham T; Olofsson T; Bautista-Molano W; Wallace ZS; Yiu ZZN; Yazdany J; Robinson PC; Smith CH
    Ann Rheum Dis; 2023 May; 82(5):698-709. PubMed ID: 36787993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.